ClinicalTrials.Veeva

Menu

Pain Neuroscience Education, Conditioned Pain Modulation and Emotional Processes in Fibromyalgia (NEUROPAINFIB)

U

University of Granada (UGR)

Status

Invitation-only

Conditions

Fibromyalgia

Treatments

Behavioral: Experimental: Pain Neuoescience Education Group
Behavioral: Active Comparator: Biomedical Education Group

Study type

Interventional

Funder types

Other

Identifiers

NCT07055971
2024/CH/01 (Other Grant/Funding Number)
NEUROPAINFIB_2025

Details and patient eligibility

About

Chronic pain represents a significant public health concern worldwide and is a primary reason why patients seek specialized medical care. Fibromyalgia (FM) is a highly prevalent chronic condition, affecting approximately 2% to 5% of the global population. Its main symptom is widespread, diffuse pain, often accompanied by joint stiffness, persistent fatigue, paresthesia, hyperalgesia, non-restorative sleep, anxiety, cognitive difficulties, and sensory hypersensitivity.

Although the exact pathophysiology of FM remains incompletely understood, alterations in central nervous system (CNS) nociceptive processing are believed to play a fundamental role in the development, propagation, and persistence of pain associated with this condition. Increased sensitivity to both painful and non-painful stimuli-known as central sensitization-may result from changes in neural function and activity, which also impact the emotional and affective regulation of pain perception and experience.

Pain neuroscience education (PNE) is an emerging therapeutic approach that focuses on helping patients reconceptualize and understand their pain through education about the neurophysiology, neuroanatomy, and neurobiology of pain. This intervention aims to promote patient awareness of the origins of their symptoms, reduce hyperactivity within the nervous system, and modify maladaptive beliefs and attitudes related to their pain experience. PNE seeks to enhance patients' capacity to manage emotional, psychological, and environmental factors that influence pain perception-such as beliefs, cultural background, motivation, and body awareness-in order to improve coping strategies in daily activities.

In this study, the investigators aim to analyze the effects of a PNE program on nociceptive processing and emotional-affective modulation in patients with FM. The hypothesis is that the intervention will lead to improvements in markers of nociceptive processing, such as pressure hyperalgesia, conditioned pain modulation (CPM), and temporal summation (TS), all of which are related to descending inhibitory pain pathways. Furthermore, the researchers anticipate enhancements in the emotional and affective mechanisms that underlie centralized pain in this population.

Enrollment

46 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Fibromyalgia in accordance with the American College of Rheumatology criteria for classifying Fibromyalgia (2016 revision) by a rheumatologist of the Public Health System of Andalusia (Spain)

Exclusion criteria

  • Presence of liver, cardiac, or renal disease.
  • Presence of previous inflammatory rheumatic disease or neurological disorders.
  • Presence of infectious processes, fever, hypotension, or respiratory alterations.
  • Severe physical disability or severe psychiatric illness.
  • Previous surgical intervention prior to the study period.
  • Presence of associated comorbidities (chemical hypersensitivity syndrome, chronic fatigue syndrome, interstitial cystitis, etc.).
  • Receiving any other non-pharmacological therapy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

46 participants in 2 patient groups

Pain Neuoescience Education
Experimental group
Treatment:
Behavioral: Experimental: Pain Neuoescience Education Group
Biomedical Education
Active Comparator group
Treatment:
Behavioral: Active Comparator: Biomedical Education Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems